57-64-7
中文名称
吡咯他尼杂质A
英文名称
PHYSOSTIGMINE SALICYLATE
CAS
57-64-7
EINECS 编号
200-343-8
分子式
C22H27N3O5
MDL 编号
MFCD00135659
分子量
413.47
MOL 文件
57-64-7.mol
更新日期
2024/04/15 13:34:25
57-64-7 结构式
基本信息
中文别名
水杨酸毒扁豆碱吡咯他尼杂质A
水杨酸毒豆碱
毒扁豆碱水杨酸盐
柳酸毒扁豆碱
水杨酸依色林
英文别名
ESERINE MONOSALICYLATEESERINE SALICYLATE
ESERINE SALICYLATE SALT
PHYSOSTIGMINE SALICYLATE
PHYSOSTIGMINE SALICYLATE SALT
2-hydroxy-,compd.with(3as-cis)-1,2,3,3a,8,8a-hexahydro-1,3a,8-benzoicaci
ar-44
physostigmine,[salicylate(1:1)]
physostigmine,salicylate(1:1)
physostolsalicylate
salicylicacid,compd.withphysostigmine(1:1)
tl-1380
trimethylpyrrolo[2,3-b]indol-5-ylmethylcarbamate(1:1)
ESERINE SALICYLATE 99.9%
Physostigmine monosalicylate
Benzoic acid, 2-hydroxy-, compd. with (3aS,8aR)-1,2,3,3a,8,8a-hexahydro-1,3a,8-trimethylpyrrolo2,3-bindol-5-yl methylcarbamate (1:1)
PHYSOSTIGMINESALICYLATE,USP
ESERINE SALICYLATE(RG)
Benzoic acid, 2-hydroxy-, compd. with (3aS,8aR)-1,2,3,3a,8,8a-hexahydro-1,3a,8-trimethylpyrrolo[2,3-b]indol-5-yl methylcarbamate (1:1) (9CI)
Benzoic acid, 2-hydroxy-, compd. with (3aS-cis)-1,2,3,3a,8,8a-hexahydro-1,3a,8-trimethylpyrrolo[2,3-b]indol-5-yl methylcarbamate (1:1)
所属类别
原料药：拟胆碱药物理化学性质
熔点181-183 °C
储存条件-20°C
溶解度DMF: 30 mg/ml,DMSO: 10 mg/ml,Ethanol: 1 mg/ml,PBS (pH 7.2): 1 mg/ml
酸度系数(pKa)pKa 1.96/8.08(H2O,t =15) (Uncertain)
形态neat
Merck7384
BRN3900576
InChIKeyHZOTZTANVBDFOF-DPKVYHSMNA-N
SMILESC12C=C(C=CC=1N(C)[C@@]1([H])N(CC[C@@]21C)C)OC(=O)NC.C1(C(=O)O)=CC=CC=C1O |&1:8,13,r|
EPA化学物质信息Physostigmine salicylate (57-64-7)
吡咯他尼杂质A价格(试剂级)
| 报价日期 | 产品编号 | 产品名称 | CAS号 | 包装 | 价格 |
| 2024/01/25 | HY-B1266 | 吡咯他尼杂质A Physostigmine salicylate | 57-64-7 | 5mg | 1400元 |
| 2024/01/25 | HY-B1266 | 吡咯他尼杂质A Physostigmine salicylate | 57-64-7 | 10mg | 2300元 |
| 2024/01/25 | HY-B1266 | 吡咯他尼杂质A Physostigmine salicylate | 57-64-7 | 25mg | 4600元 |
常见问题列表
生物活性
Physostigmine salicylate (Eserine salicylate) 是一种可逆的乙酰胆碱酯酶 (AChE) 抑制剂。Physostigmine salicylate 可以透过血脑屏障并刺激中枢胆碱能神经传递。Physostigmine salicylate 能逆转阿尔茨海默病转基因小鼠的记忆缺陷。Physostigmine salicylate 也是抗胆碱能中毒的解毒剂。体内研究
Physostigmine salicylate (Eserine salicylate; 0.03-0.3 mg/kg; s.c.; daily for 6 weeks) improves deficits in contextual and cued memory in Tg(+) mice.
Physostigmine salicylate (IV; 0.1, 0.2 mg/kg) delays time to emergence from isoflurane anesthesia at doses ≥0.2 mg/kg in male Sprague-Dawley rats.
| Animal Model: | Heterozygous transgenic mice (Tg(+) mice) |
| Dosage: | 0.03, 0.1, and 0.3 mg/kg |
| Administration: | SC; daily for 6 weeks |
| Result: | Tended to normalize the contextual memory deficit in Tg(+) animals so that they became more similar to Tg(-) animals. |